This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
As the COVID-19 national emergency stretches on in the United States, the eyes of the. The post What to Expect from the FDA During COVID-19 Product Development appeared first on Camargo.
PharmacyChecker pays close attention and has performed considerable research related to where drugs are made. Most notably, by researching drug labels and contacting drug companies, we found that 71% of brand name drugs sold in the U.S. are foreign made , a number far higher than the 40% figure regurgitated by the FDA year after year. Americans care a lot about this issue.
If you are new to the clinical research industry, it’s important to know how clinical studies are developed and run. The basis for all such studies is the study protocol, about which this piece will provide a high-level overview. A study protocol is a document that provides an overview of the study. It includes information such as design, objectives, and methodology, and guides research conduct during the study.
Based on recent SCRS survey data , a vast majority of research sites (58%) anticipate that COVID-19 will negatively affect their clinical trial enrollment and nearly half of respondents (47%) feel COVID-19 will have a negative effect on retention. With the number of new cases increasing daily, these expectations are, unfortunately, likely to be correct. .
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
When you hear ‘clinical trials,’ today you think about research sites, hospitals, and doctor’s offices. What you absolutely don’t think about is a British Royal Navy fleet ship ridden with scurvy, but that’s how clinical trials started! On this day, 273 years ago, surgeon mate James Lind conducted a clinical trial to advance medicine for. Read more Clinical Trial Day: Celebrating 273 Years of Medical Advancements.
COVID-19 was a shock to the system unlike anything that had been anticipated. Even prior to the shutdown, health-perceptive people were starting to avoid public venues and there were declines in the numbers of people going out to eat at restaurants, to public functions, visiting with friends and also going to the doctor’s offices. When it comes to healthcare, that has translated into multiple stress points to our system of care spanning both health and economics with people avoiding care f
In Copay Maximizers Are Displacing Accumulators—But CMS Ignores How Payers Leverage Patient Support , I explained a new Centers for Medicare and Medicaid Services (CMS) final rule regarding health plans’ use of copay accumulator adjustment. I also highlighted why plans have responded to the negative patient impact from accumulators with copay maximizer programs.
In Copay Maximizers Are Displacing Accumulators—But CMS Ignores How Payers Leverage Patient Support , I explained a new Centers for Medicare and Medicaid Services (CMS) final rule regarding health plans’ use of copay accumulator adjustment. I also highlighted why plans have responded to the negative patient impact from accumulators with copay maximizer programs.
[link]. Cloudbyz Budget management solution is an integrated end-to-end solution that enables all the stakeholders, ie Sponsors, CRO’s and Sites to gain visibility, control and flexibility in managing the financials across clinical trial projects. The solution helps in accelerating study budget management with a high level of accuracy and minimal manual effort.
As the situation with COVID-19 continues to change, we wanted to let you know that Carton Service/Pharma Packaging Solutions is defined as an Essential Industry due to the life-sustaining products we produce. Even with communities establishing Shelter-In-Place or Safer-At-Home orders, our associates have been notified that they are essential workers.
There is a popular saying: “It’s difficult to make predictions, especially about the future.” Correct, but that didn’t stop me from asking Imperial leadership for their thoughts on what we might see in the years to come. Balancing innovation and risk. The COVID-19 pandemic has created a phenomenon impacting both personal and professional lives — “COVID Time.
The Problem With Staying At Your Job Too Long Don't forget to Subscribe for new content! Subscribe: [link] Call or Text: 910-502-3732 Email: eliteclinicalgroup@gmail.com Podcast: [link] Steemit: [link] Advertise: eliteclinicalgroup@gmail.com Watch: » Industry News: [link] » All Videos: [link] » Interview Recaps: [link] » Glassdoor Reviews: [link] We do: » Insider Interviews » Resume Reviews » Question and Answer » Discuss all things Clinical Research » News and Product Reviews » Education Send i
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
COVID-19 has not stopped the wheels of policy bureaucracy from grinding. Last week, the Centers for Medicare and Medicaid Services (CMS) released its final Notice of Benefit and Payment Parameters for the 2021 benefit year. You’ll find the document links below. This final rule permits insurers to exclude the value of a pharmaceutical manufacturer’s copay support program from a patient’s annual deductible and out-of-pocket maximum obligations.
Client-Pharma is committed to providing a first-class service to clients all over the world, and closer to home they pledged to serve the local community that emulates their core company values. Since the UK lock-down began, Client-Pharma teamed up with a local restaurant to provide fresh hot meals daily for neighborhoods in a local town close to the office HQ.
The Problem With Staying At Your Job Too Long. Don't forget to Subscribe for new content! Subscribe: [link] Call or Text: 910-502-3732 Email: eliteclinicalgroup@gmail.com Podcast: [link] Steemit: [link] Advertise: eliteclinicalgroup@gmail.com Watch: » Industry News: [link] » All Videos: [link] » Interview Recaps: [link] » Glassdoor Reviews: [link] We do: » Insider Interviews » Resume Reviews » Question and Answer » Discuss all things Clinical Research » News and Product Reviews » Education.
Today’s guest post comes from Kyle Grimslid, Market Development Director at CoverMyMeds. Kyle describes the complications that providers and patients encounter in the specialty prescription process. He describes how AMP: Access for more Patients™ enhances access, affordability and adherence—including a reported 27% reduction in time to therapy. Click here to learn more about how CoverMyMeds and RxCrossroads by McKesson are using technology to solve patients' medication access challenges.
Client-Pharma is committed to providing a first-class service to clients all over the world, and closer to home they pledged to serve the local community that emulates their core company values. Since the UK lock-down began, Client-Pharma teamed up with a local restaurant to provide fresh hot meals daily for neighborhoods in a local town close to the office HQ.
We are monitoring the COVID-19 situation very closely. We are confident we can abide by any imposed guidelines while continuing to seamlessly support our customers’ business operations. Because we care about our associates, our customers and our communities, we want to share the steps we are taking during this fluid and changing situation. We do have an active business continuity plan to keep our customers, our visitors, our associates and their families safe and healthy.
AUTHORS : Gouranga Sundar Roy 1 *, Sangita Biswas 2 . Department of Pharmacy, Bengal School of Technology. (A College of Pharmacy), Sugandha, Delhi Road Near Chuchura, Hooghly - 712102, West Bengal, India. ABSTRACT: Scott Craniodigital syndrome is a situation that has best been found in families. The manifestations consist of uncommon head shape, boom and developmental delay, and mild webbing between the arms and toes.
Glasgow, Scotland, 21 May 2020 - Amphista Therapeutics, a biopharmaceutical company creating first-in-class cancer therapeutics that harness the body’s natural processes to remove disease causing proteins selectively and efficiently, today announced the appointment of Dr Ian Churcher as Chief Scientific Officer (CSO).
A ‘virtual VMIC’ will be created to rapidly expand the UK capacity to manufacture a COVID-19 vaccine. VMIC’s permanent facility, currently being built, will be fast tracked to come online in Summer 2021 – a year ahead of schedule. Manufacturing output at the permanent facility will be scaled-up 20fold to ensure enough doses of a pandemic vaccine for the UK population within 4-6 months of opening.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content